JP2011518115A5 - - Google Patents

Download PDF

Info

Publication number
JP2011518115A5
JP2011518115A5 JP2010543588A JP2010543588A JP2011518115A5 JP 2011518115 A5 JP2011518115 A5 JP 2011518115A5 JP 2010543588 A JP2010543588 A JP 2010543588A JP 2010543588 A JP2010543588 A JP 2010543588A JP 2011518115 A5 JP2011518115 A5 JP 2011518115A5
Authority
JP
Japan
Prior art keywords
cancer
pharmaceutical composition
composition according
tapasin
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010543588A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011518115A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2009/005030 external-priority patent/WO2009095796A2/en
Publication of JP2011518115A publication Critical patent/JP2011518115A/ja
Publication of JP2011518115A5 publication Critical patent/JP2011518115A5/ja
Pending legal-status Critical Current

Links

JP2010543588A 2008-01-28 2009-01-27 免疫応答を増強するためのタパシン増加 Pending JP2011518115A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2400408P 2008-01-28 2008-01-28
US61/024,004 2008-01-28
PCT/IB2009/005030 WO2009095796A2 (en) 2008-01-28 2009-01-27 Tapasin augmentation for enhanced immune response

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014130452A Division JP2014196338A (ja) 2008-01-28 2014-06-25 免疫応答を増強するためのタパシン増加

Publications (2)

Publication Number Publication Date
JP2011518115A JP2011518115A (ja) 2011-06-23
JP2011518115A5 true JP2011518115A5 (cg-RX-API-DMAC10.html) 2011-08-11

Family

ID=40913348

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010543588A Pending JP2011518115A (ja) 2008-01-28 2009-01-27 免疫応答を増強するためのタパシン増加
JP2014130452A Pending JP2014196338A (ja) 2008-01-28 2014-06-25 免疫応答を増強するためのタパシン増加

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014130452A Pending JP2014196338A (ja) 2008-01-28 2014-06-25 免疫応答を増強するためのタパシン増加

Country Status (8)

Country Link
US (1) US20110117137A1 (cg-RX-API-DMAC10.html)
EP (1) EP2247309A4 (cg-RX-API-DMAC10.html)
JP (2) JP2011518115A (cg-RX-API-DMAC10.html)
KR (1) KR20110011595A (cg-RX-API-DMAC10.html)
CN (1) CN102159241A (cg-RX-API-DMAC10.html)
AU (1) AU2009208735A1 (cg-RX-API-DMAC10.html)
CA (1) CA2712964A1 (cg-RX-API-DMAC10.html)
WO (1) WO2009095796A2 (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111836635A (zh) 2018-01-26 2020-10-27 剑桥企业有限公司 肽交换蛋白

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996009380A1 (en) * 1994-09-23 1996-03-28 The University Of British Columbia Method of enhancing expression of mhc class i molecules bearing endogenous peptides
US6479258B1 (en) * 1995-12-07 2002-11-12 Diversa Corporation Non-stochastic generation of genetic vaccines
US6713279B1 (en) * 1995-12-07 2004-03-30 Diversa Corporation Non-stochastic generation of genetic vaccines and enzymes
US6171820B1 (en) * 1995-12-07 2001-01-09 Diversa Corporation Saturation mutagenesis in directed evolution
US6692923B2 (en) * 1999-04-14 2004-02-17 Incyte Corporation Tapasin-like protein
EP1363938B1 (en) * 2000-08-03 2013-12-11 Johns Hopkins University Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
IL155791A0 (en) * 2000-11-08 2003-12-23 Einstein Coll Med Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and uses thereof
GB0328248D0 (en) * 2003-12-05 2004-01-07 Oxford Biomedica Ltd Method

Similar Documents

Publication Publication Date Title
Verardi et al. A vaccinia virus renaissance: new vaccine and immunotherapeutic uses after smallpox eradication
ES2848064T3 (es) Vacuna terapéutica potenciadora de inmunidad para VPH y enfermedades relacionadas
Pol et al. Trial watch: oncolytic viruses for cancer therapy
Vacchelli et al. Trial watch: Oncolytic viruses for cancer therapy
Janke et al. Recombinant Newcastle disease virus (NDV) with inserted gene coding for GM-CSF as a new vector for cancer immunogene therapy
Guse et al. Oncolytic vaccinia virus for the treatment of cancer
ES2522042T3 (es) Composición de vacuna que comprende un ARN modificado con caperuza 5'
US12220456B2 (en) Compositions and methods for organ-protective expression and modulation of coding ribonucleic acids
Knudson et al. Lipid-nanoparticle-encapsulated mRNA vaccines induce protective memory CD8 T cells against a lethal viral infection
JP2017514483A5 (cg-RX-API-DMAC10.html)
JP2008056679A5 (cg-RX-API-DMAC10.html)
JP2016516723A5 (cg-RX-API-DMAC10.html)
Duan et al. Oncolytic Virus‐Driven Biotherapies From Bench to Bedside
MX2020000221A (es) Secuencias de aminoacidos y de acidos nucleicos de adenovirus de grandes simios no humanos, vectores que contienen las mismas y usos de las mismas.
JP2018526321A (ja) 適応免疫応答を誘導するためのヌクレオシド修飾ｒｎａ
WO2014063601A1 (zh) 诱导肿瘤特异性免疫的疫苗及其应用
Schmidt et al. Live-attenuated lymphocytic choriomeningitis virus-based vaccines for active immunotherapy of HPV16-positive cancer
Xie et al. Overcoming suppressive tumor microenvironment by vaccines in solid tumor
Liu et al. Therapeutic use of tumor cell-derived extracellular vesicles
Öhlschläger et al. Enhancement of immunogenicity of a therapeutic cervical cancer DNA‐based vaccine by co‐application of sequence‐optimized genetic adjuvants
Xu et al. Advanced nanomedicine for high-risk HPV-driven head and neck cancer
CN121038810A (zh) 针对冠状病毒感染、流行性感冒感染和/或rsv感染的组合疫苗
US11331343B2 (en) Compositions and methods for activating antigen presenting cells with chimeric poliovirus
Bahreyni Development of a safe treatment for breast cancer using an oncolytic Coxsackievirus B3
YANG et al. Nucleic acid-based vaccines of COVID-19 and their delivery systems